Tandem Diabetes Care Inc (TNDM)

Official site

HEALTHCARE • MEDICAL DEVICES • NASDAQ

$16.01

-0.64 (-3.84%)

Market Cap: $1.11B

Last updated: Oct 16, 2026 at 1:55 PM ET

Earnings

Performance (10Y)

Beat Rate

56%(22/39)

Avg Surprise

-41.86%

Streak

4 Q

Upcoming Estimates

Period ending Sep 30, 2026

EPS Consensus$-0.24

Range$-0.36 - $-0.16

19 analysts

EPS Revisions

30d

EPS Estimate DriftChange to current

90d ago$-0.20-22.5%

60d ago$-0.18-34.8%

30d ago$-0.240.0%

7d ago$-0.240.0%

Current$-0.24

Revenue Consensus

$266M

Range$263M - $270M

22 analysts

Period ending Dec 31, 2026

EPS Consensus$0.34

Range$0.09 - $0.55

20 analysts

Revenue Consensus

$311M

Range$302M - $320M

24 analysts

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$0.34	$0.09 - $0.55	-	-	20	-	-
Sep 30, 2026Sep 26EST	-	$-0.24	$-0.36 - $-0.16	-	-	19	3 12 30d	-
Jun 30, 2026Jun 26 Reported Aug 6, 2026Reported Aug 6	$-0.31	$-0.34	$-0.41 - $-0.23	+8.82%	Beat	18	1 3 30d	+35.4%
Mar 31, 2026Mar 26 Reported May 7, 2026Reported May 7	$-0.30	$-0.44	$-0.54 - $-0.35	+31.82%	Beat	18	5 10 30d	+55.2%
Dec 31, 2025Dec 25 Reported Feb 19, 2026Reported Feb 19	$-0.01	N/A	-	+88.89%	Beat	21	2 1 30d	+97.7%
Sep 30, 2025Sep 25 Reported Nov 6, 2025Reported Nov 6	$-0.31	$-0.34	$-0.54 - $-0.07	+8.82%	Beat	20	3 15 30d	+13.9%
Jun 30, 2025Jun 25 Reported Aug 6, 2025Reported Aug 6	$-0.48	$-0.40	$-0.57 - $-0.26	-20.00%	Miss	20	1 0 30d	+0.0%
Mar 31, 2025Mar 25 Reported Apr 30, 2025Reported Apr 30	$-0.67	$-0.61	$-0.67 - $-0.49	-9.84%	Miss	20	0 1 30d	-4.7%
Dec 31, 2024Dec 24 Reported Feb 26, 2025Reported Feb 26	$-0.44	$-0.24	$-0.37 - $-0.05	-84.81%	Miss	17	2 9 30d	-61.3%
Sep 30, 2024Sep 24 Reported Nov 6, 2024Reported Nov 6	$-0.36	$-0.41	$-0.50 - $-0.27	+12.20%	Beat	19	1 0 30d	+5.3%
Jun 30, 2024Jun 24 Reported Aug 1, 2024Reported Aug 1	$-0.48	$-0.53	$-0.61 - $-0.35	+9.43%	Beat	11	No revisions (30d)	-60.0%
Mar 31, 2024Mar 24 Reported May 2, 2024Reported May 2	$-0.64	$-0.76	$-0.85 - $-0.58	+15.79%	Beat	12	No revisions (30d)	-1.6%
Dec 31, 2023Dec 23 Reported Feb 21, 2024Reported Feb 21	$-0.27	$-0.25	$-0.40 - $-0.10	-8.00%	Miss	13	No revisions (30d)	-8.0%
Sep 30, 2023Sep 23 Reported Nov 1, 2023Reported Nov 1	$-0.38	$-0.36	$-0.59 - $0.02	-5.56%	Miss	14	No revisions (30d)	-40.7%
Jun 30, 2023Jun 23 Reported Aug 3, 2023Reported Aug 3	$-0.30	$-0.49	$-0.63 - $-0.43	+38.78%	Beat	8	No revisions (30d)	-30.4%
Mar 31, 2023Mar 23 Reported May 3, 2023Reported May 3	$-0.63	$-0.53	$-0.69 - $-0.26	-18.87%	Miss	12	No revisions (30d)	-173.9%
Dec 31, 2022Dec 22 Reported Feb 22, 2023Reported Feb 22	$-0.25	$-0.06	$-0.22 - $0.07	-316.67%	Miss	13	No revisions (30d)	-256.3%
Sep 30, 2022Sep 22 Reported Nov 2, 2022Reported Nov 2	$-0.27	$-0.05	$-0.18 - $0.06	-440.00%	Miss	13	No revisions (30d)	-400.0%
Jun 30, 2022Jun 22 Reported Aug 3, 2022Reported Aug 3	$-0.23	$0.02	$-0.04 - $0.17	-1250.00%	Miss	11	0 1 30d	-483.3%
Mar 31, 2022Mar 22 Reported May 4, 2022Reported May 4	$-0.23	$-0.07	$-0.23 - $0.17	-228.57%	Miss	11	3 0 30d	-187.5%
Dec 31, 2021Dec 21 Reported Feb 22, 2022Reported Feb 22	$0.16	$0.21	$0.10 - $0.33	-23.81%	Miss	12	No revisions (30d)	-27.3%
Sep 30, 2021Sep 21 Reported Nov 3, 2021Reported Nov 3	$0.09	$0.06	$-0.02 - $0.18	+50.00%	Beat	15	1 0 30d	+160.0%
Jun 30, 2021Jun 21 Reported Aug 4, 2021Reported Aug 4	$0.06	$-0.08	$-0.28 - $0.03	+175.00%	Beat	15	No revisions (30d)	+113.3%
Mar 31, 2021Mar 21 Reported May 5, 2021Reported May 5	$-0.08	$-0.15	$-0.28 - $-0.04	+46.67%	Beat	14	No revisions (30d)	+68.0%
Dec 31, 2020Dec 20 Reported Feb 24, 2021Reported Feb 24	$0.22	$0.12	$0.03 - $0.23	+83.33%	Beat	14	No revisions (30d)	+450.0%
Sep 30, 2020Sep 20 Reported Nov 5, 2020Reported Nov 5	$-0.15	$-0.12	$-0.28 - $0.05	-25.00%	Miss	15	No revisions (30d)	-66.7%
Jun 30, 2020Jun 20 Reported Jul 30, 2020Reported Jul 30	$-0.45	$-0.25	$-0.35 - $-0.09	-80.00%	Miss	14	1 0 30d	-1400.0%
Mar 31, 2020Mar 20 Reported Apr 30, 2020Reported Apr 30	$-0.25	$-0.18	$-0.29 - $-0.08	-38.89%	Miss	14	No revisions (30d)	+37.5%
Dec 31, 2019Dec 19 Reported Feb 24, 2020Reported Feb 24	$0.04	$-0.05	$-0.21 - $0.10	+180.00%	Beat	13	No revisions (30d)	+100.0%
Sep 30, 2019Sep 19 Reported Nov 4, 2019Reported Nov 4	$-0.09	N/A	-	+59.09%	Beat	12	No revisions (30d)	+70.0%
Jun 30, 2019Jun 19 Reported Aug 1, 2019Reported Aug 1	$-0.03	N/A	-	+89.66%	Beat	12	1 0 30d	+90.9%
Mar 31, 2019Mar 19 Reported Apr 30, 2019Reported Apr 30	$-0.40	$-0.29	$-0.41 - $-0.14	-37.93%	Miss	12	No revisions (30d)	+61.2%
Dec 31, 2018Dec 18 Reported Feb 26, 2019Reported Feb 26	$0.02	N/A	-	+110.00%	Beat	11	No revisions (30d)	+101.6%
Sep 30, 2018Sep 18 Reported Nov 1, 2018Reported Nov 1	$-0.30	$-0.31	$-0.46 - $-0.21	+3.23%	Beat	10	No revisions (30d)	+91.6%
Jun 30, 2018Jun 18 Reported Jul 30, 2018Reported Jul 30	$-0.33	$-0.33	$-0.39 - $-0.31	+0.00%	Beat	6	No revisions (30d)	+92.5%
Mar 31, 2018Mar 18 Reported Apr 26, 2018Reported Apr 26	$-1.03	$-0.62	$-0.74 - $-0.45	-66.13%	Miss	6	1 0 30d	+86.3%
Dec 31, 2017Dec 17 Reported Mar 1, 2018Reported Mar 1	$-1.22	$-1.30	$-1.87 - $-1.02	+6.15%	Beat	5	2 0 30d	+78.0%
Sep 30, 2017Sep 17 Reported Oct 26, 2017Reported Oct 26	$-3.59	$-3.74	-	+4.01%	Beat	-	-	-
Jun 30, 2017Jun 17 Reported Jul 27, 2017Reported Jul 27	$-4.40	$-4.79	-	+8.14%	Beat	-	-	-
Mar 31, 2017Mar 17 Reported Apr 27, 2017Reported Apr 27	$-7.50	$-6.11	-	-22.75%	Miss	-	-	-
Dec 31, 2016Dec 16 Reported Mar 8, 2017Reported Mar 8	$-5.55	$-6.49	-	+14.48%	Beat	-	-	-

Key Metrics

Valuation
P/E Ratio	-17.22	EV/EBITDA	N/A
Price/FCF	-41.51x	FCF Yield	-2.41%
Profitability
Profit Margin	-6.08%	Operating Margin	-5.42%
ROE	-48.00%	ROIC	-6.25%
Financial Health
Debt/Equity	4.62x	Interest Coverage	-5.21x
Current Ratio	3.18x	Quick Ratio	2.65x
Trading Statistics
Beta	1.66	Avg Volume	2.31M
52-Week High	$29.65	52-Week Low	$12.26

Technical Indicators Dashboard

Moving Averages

SMA 10$16.24

SMA 20$16.41

SMA 50$19.12

SMA 200$19.19

EMA 10$16.28

EMA 20$16.71

EMA 50$17.73

EMA 200$18.35

MACD

Line: -0.67Signal: -0.82Hist: 0.14

ADX

ADX: 19.3+DI: 18.0-DI: 20.3

Aroon & PSAR

Aroon UpN/A

Aroon Down48.0

PSAR$15.21

Bollinger Bands

Upper Band$17.60

Lower Band$15.22

%B Position1450%(Upper)

Band Width0.33

RSI (14-Day)

Neutral

40.4

Momentum Oscillators

Stoch %K58.7

Stoch %D52.1

Williams %R-53.2

ROC (10d)-1.8%

Momentum-0.30

CCI (20d)-36.6

MFI (14d)41.9

Volatility Measures

ATR (14d)$1.00(6.2%)

StdDev (20d)0.60

Hist Vol50.0%(High)

Volume Flow

VWAP$16.19

OBV-6.0M

AD Line-10.5M

CMF (20d)0.035

Volume Metrics

Avg Vol (20d)2.2M

Vol Ratio1.0x

VWMA (20d)$16.39

Pivot Points

R3$18.15

R2$17.47

R1$17.06

Pivot Point$16.39

S1$15.98

S2$15.30

S3$14.89

Advanced Oscillators

TSI-21.35

Ultimate Osc51.4

KST-158.48

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$254.56M	$247.22M	$290.38M	$249.25M	$240.68M	$234.42M	$282.65M	$243.97M	$221.91M	$191.67M	$196.80M	$185.62M
Cost of Revenue	$109.78M	$110.43M	$122.92M	$114.96M	$114.82M	$116.02M	$125.19M	$119.32M	$109.12M	$97.00M	$103.50M	$95.87M
Gross Profit	$144.78M	$136.79M	$167.46M	$134.29M	$125.86M	$118.41M	$157.46M	$124.65M	$112.79M	$94.67M	$93.30M	$89.75M

Operating Expenses	$158.57M	$154.22M	$159.17M	$157.16M	$177.66M	$239.28M	$158.04M	$150.75M	$143.57M	$136.35M	$128.35M	$121.30M
R&D	$46.93M	$46.03M	$46.07M	$48.72M	$48.12M	$125.43M	$52.20M	$51.11M	$49.33M	$46.24M	$42.60M	$41.97M
SG&A	$111.64M	$108.19M	$113.10M	$108.44M	$109.60M	$113.85M	$105.84M	$99.64M	$94.24M	$90.11M	$85.75M	$79.33M
Operating Income	$-13,792,000	$-17,434,000	$8.29M	$-22,863,000	$-51,810,000	$-120,878,000	$-582,000	$-26,093,000	$-30,774,000	$-41,678,000	$-35,060,000	$-31,545,000

Interest Income	$-4,416,000	$-239,000	$-1,537,000	$-215,000	$-4,007,000	$651,000	$2.46M	$5.34M	$2.82M	$5.31M	$5.55M	$5.66M
Interest Expense	$2.45M	$2.20M	$2.08M	$2.06M	$1.91M	$1.86M	$1.86M	$1.86M	$1.79M	$3.17M	$1.80M	$4.84M
Income Before Tax	$-20,658,000	$-19,877,000	$4.68M	$-25,143,000	$-57,722,000	$-122,089,000	$16,000	$-22,614,000	$-29,743,000	$-39,529,000	$-31,310,000	$-30,729,000
Income Tax Expense	$510,000	$516,000	$5.27M	$-3,978,000	$-5,322,000	$8.47M	$-739,000	$637,000	$1.07M	$3.19M	$-1,308,000	$2.23M

Net Income	$-21,168,000	$-20,393,000	$-589,000	$-21,165,000	$-52,400,000	$-130,556,000	$755,000	$-23,251,000	$-30,814,000	$-42,715,000	$-30,002,000	$-32,961,000

EBITDA	$-9,588,000	$-13,101,000	$11.49M	$-18,229,000	$-47,610,000	$-117,210,000	$2.44M	$-22,323,000	$-25,449,000	$-37,419,000	$-30,126,000	$-25,398,000
EBIT	$-13,792,000	$-17,434,000	$8.29M	$-22,863,000	$-51,810,000	$-120,878,000	$-582,000	$-26,093,000	$-30,774,000	$-41,678,000	$-35,060,000	$-31,545,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about TNDM

News

Tandem CEO Sheridan Says New Tubeless Pump Wins on Outcomes, Not Form Factor

Tandem Diabetes CEO John Sheridan believes the company's new tubeless Mobi pump, combined with a pharmacy-channel pay-as-you-go model and an advanced closed-loop algorithm...

BigGo Finance•Oct 15, 2026 10:41 AM ET10/15/26•Bullish

Mizuho cuts target from USD 20 to USD 18 for Tandem Diabetes Care stock

Mizuho has cut its price target for Tandem Diabetes Care (TNDM) stock from USD 20 to USD 18, maintaining a Neutral rating. This adjustment comes despite a 5.77% year-over-year increase in Q2 sales to USD 254.56 million...

ad-hoc-news.de•Oct 15, 2026 7:09 AM ET10/15/26•Somewhat-Bearish

Price-Driven Insight from (TNDM) for Rule-Based Strategy

This article provides a price-driven insight into Tandem Diabetes Care Inc. (NASDAQ: TNDM) for rule-based trading strategies. It highlights a neutral near-term sentiment that could moderate mid-term weakness...

Stock Traders Daily•Oct 14, 2026 9:13 AM ET10/14/26•Somewhat-Bearish

Tandem Diabetes Care Q2 2026 Earnings Call Transcript

Tandem Diabetes Care reported strong Q2 2026 results, with worldwide pump shipments up over 10% year-over-year and significant gross margin improvement. The company's strategic initiatives...

Benzinga•Oct 12, 2026 6:12 AM ET10/12/26•Bullish

App Recall Might Change The Case For Investing In Tandem Diabetes Care (TNDM)

Tandem Diabetes Care (TNDM) has issued a Class II recall for its iOS t:slim mobile app version 2.13 due to a pairing issue that disrupted automated insulin delivery for 177 beta users. This incident highlights...

Simply Wall Street•Oct 11, 2026 7:10 AM ET10/11/26•Somewhat-Bearish

TNDM Valuation and Fair Value

P/E: -17.2x
Forward P/E: 117.7x
P/FCF: -41.5x
PEG: 0.0x
P/B: 8.5x

See GNG's fair value

TNDM Profitability: Margins, ROIC and FCF

Gross margin: 56.0%
Operating margin: -5.4%
Net margin: -6.1%
ROIC: -6.2%
ROE: -48.0%
FCF margin: -2.6%
FCF yield: -2.4%

TNDM Competitors

Company	Ticker
Omada Health, Inc. Common Stock	OMDA
Amphastar P	AMPH
Vor Biopharma Inc	VOR
STAAR Surgical Company	STAA
Taysha Gene Therapies Inc	TSHA
Teladoc Inc	TDOC
Iradimed Co	IRMD
Procept Biorobotics Corp	PRCT

Sector: Healthcare

TNDM Analyst Ratings

Consensus: Buy
Analysts: 24
Strong Buy: 3
Buy: 11
Hold: 10
Sell: 0
Strong Sell: 0

TNDM Bull Case vs Bear Case

Bear case

TNDM has a -6.1% net profit margin.
TNDM has a debt-to-equity ratio of 4.6x.

TNDM Earnings: Beat Rate and Next Report

Beat rate: 5 of 8 quarters (62.5%)
Average surprise: 4.5%
EPS estimate (fiscal period ending Sep 30, 2026): $-0.24
Estimate revisions (30 days, fiscal period ending Sep 30, 2026): 3 up, 12 down

Frequently Asked Questions About TNDM

Does TNDM pay dividends?

Tandem Diabetes Care Inc (TNDM) does not currently pay a regular dividend.

What is TNDM's market cap?

Tandem Diabetes Care Inc (TNDM) has a market capitalization of $1.11B with a current stock price of $16.01.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In